- Home
- Publications
- Publication Search
- Publication Details
Title
The influence of BRCA2 mutation on localized prostate cancer
Authors
Keywords
-
Journal
Nature Reviews Urology
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-02-26
DOI
10.1038/s41585-019-0164-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular landmarks of tumor hypoxia across cancer types
- (2019) Vinayak Bhandari et al. NATURE GENETICS
- Widespread and Functional RNA Circularization in Localized Prostate Cancer
- (2019) Sujun Chen et al. CELL
- Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition
- (2018) Christos Mikropoulos et al. BRITISH JOURNAL OF CANCER
- The Evolutionary Landscape of Localized Prostate Cancers Drives Clinical Aggression
- (2018) Shadrielle Melijah G. Espiritu et al. CELL
- Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19
- (2018) Junjie Tony Hua et al. CELL
- Active surveillance of men with low risk prostate cancer: evidence from the Prostate Cancer Outcomes Registry-Victoria
- (2018) Melanie A Evans et al. MEDICAL JOURNAL OF AUSTRALIA
- The long tail of oncogenic drivers in prostate cancer
- (2018) Joshua Armenia et al. NATURE GENETICS
- Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets
- (2018) David C. Wedge et al. NATURE GENETICS
- Historical and contemporary perspectives on cribriform morphology in prostate cancer
- (2018) Matthew Truong et al. Nature Reviews Urology
- Preclinical Models of Prostate Cancer: Patient-Derived Xenografts, Organoids, and Other Explant Models
- (2018) Gail P. Risbridger et al. Cold Spring Harbor Perspectives in Medicine
- Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories
- (2018) Clarissa Gerhauser et al. CANCER CELL
- Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer
- (2018) H. Ballentine Carter et al. EUROPEAN UROLOGY
- Active surveillance for prostate and thyroid cancers: evolution in clinical paradigms and lessons learned
- (2018) Lisa M. Lowenstein et al. Nature Reviews Clinical Oncology
- Systematic Review Links the Prevalence of Intraductal Carcinoma of the Prostate to Prostate Cancer Risk Categories
- (2017) Laura H. Porter et al. EUROPEAN UROLOGY
- A Prostate Cancer “ Nimbosus ”: Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies
- (2017) Melvin L.K. Chua et al. EUROPEAN UROLOGY
- The Evolving Narrative of DNA Repair Gene Defects: Distinguishing Indolent from Lethal Prostate Cancer
- (2017) Declan G. Murphy et al. EUROPEAN UROLOGY
- Genomic hallmarks of localized, non-indolent prostate cancer
- (2017) Michael Fraser et al. NATURE
- Management of Biochemical Recurrence after Primary Curative Treatment for Prostate Cancer: A Review
- (2017) Walter Artibani et al. UROLOGIA INTERNATIONALIS
- Crucial role of noncoding RNA in driving prostate cancer development and progression
- (2017) Haiyang Guo et al. Epigenomics
- Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories
- (2017) Renea A. Taylor et al. Nature Communications
- Mitochondrial mutations drive prostate cancer aggression
- (2017) Julia F. Hopkins et al. Nature Communications
- A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score
- (2016) Jonathan I. Epstein et al. EUROPEAN UROLOGY
- Prostate cancer
- (2016) Gerhardt Attard et al. LANCET
- The presence of intraductal carcinoma of the prostate in needle biopsy is a significant prognostic factor for prostate cancer patients with distant metastasis at initial presentation
- (2016) Masashi Kato et al. MODERN PATHOLOGY
- Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
- (2016) Colin C. Pritchard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer
- (2016) Yunee Kim et al. Nature Communications
- High burden of copy number alterations andc-MYCamplification in prostate cancer fromBRCA2germline mutation carriers
- (2015) E. Castro et al. ANNALS OF ONCOLOGY
- Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
- (2015) S. Gillessen et al. ANNALS OF ONCOLOGY
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- The Molecular Taxonomy of Primary Prostate Cancer
- (2015) Adam Abeshouse et al. CELL
- Patient-derived Xenografts Reveal that Intraductal Carcinoma of the Prostate Is a Prominent Pathology in BRCA2 Mutation Carriers with Prostate Cancer and Correlates with Poor Prognosis
- (2015) Gail P. Risbridger et al. EUROPEAN UROLOGY
- Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer
- (2015) Elena Castro et al. EUROPEAN UROLOGY
- Spatial genomic heterogeneity within localized, multifocal prostate cancer
- (2015) Paul C Boutros et al. NATURE GENETICS
- Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue
- (2015) Colin S Cooper et al. NATURE GENETICS
- DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
- (2015) Joaquin Mateo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Establishment of primary patient-derived xenografts of palliative TURP specimens to study castrate-resistant prostate cancer
- (2015) Mitchell G. Lawrence et al. PROSTATE
- The presence and clinical implication of intraductal carcinoma of prostate in metastatic castration resistant prostate cancer
- (2015) Zhibin Chen et al. PROSTATE
- Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study
- (2014) Elizabeth K. Bancroft et al. EUROPEAN UROLOGY
- Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
- (2014) Emilie Lalonde et al. LANCET ONCOLOGY
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Copy number alteration burden predicts prostate cancer relapse
- (2014) H. Hieronymus et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prognostic value of intraductal carcinoma of the prostate in radical prostatectomy specimens
- (2014) Kyosuke Kimura et al. PROSTATE
- Integrative Genomic Analyses Reveal an Androgen-Driven Somatic Alteration Landscape in Early-Onset Prostate Cancer
- (2013) Joachim Weischenfeldt et al. CANCER CELL
- Punctuated Evolution of Prostate Cancer Genomes
- (2013) Sylvan C. Baca et al. CELL
- GermlineBRCAMutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer
- (2013) Elena Castro et al. JOURNAL OF CLINICAL ONCOLOGY
- 4FISH-IF, a Four-Color Dual-Gene FISH Combined with p63 Immunofluorescence to Evaluate NKX3.1 and MYC Status in Prostate Cancer
- (2013) Dominique Trudel et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- A preclinical xenograft model of prostate cancer using human tumors
- (2013) Mitchell G Lawrence et al. Nature Protocols
- A Preclinical Xenograft Model Identifies Castration-Tolerant Cancer-Repopulating Cells in Localized Prostate Tumors
- (2013) R. Toivanen et al. Science Translational Medicine
- Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy
- (2012) Gaetano Zafarana et al. CANCER
- Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy
- (2012) T. Van der Kwast et al. EUROPEAN JOURNAL OF CANCER
- Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study
- (2012) Meelan Bul et al. EUROPEAN UROLOGY
- Identification of Differentially Expressed Proteins in Direct Expressed Prostatic Secretions of Men with Organ-confinedVersusExtracapsular Prostate Cancer
- (2012) Yunee Kim et al. MOLECULAR & CELLULAR PROTEOMICS
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
- (2012) Christopher E Barbieri et al. NATURE GENETICS
- Risk stratification in prostate cancer screening
- (2012) Monique J. Roobol et al. Nature Reviews Urology
- NKX3.1 Haploinsufficiency Is Prognostic for Prostate Cancer Relapse following Surgery or Image-Guided Radiotherapy
- (2011) J. A. Locke et al. CLINICAL CANCER RESEARCH
- The genomic complexity of primary human prostate cancer
- (2011) Michael F. Berger et al. NATURE
- Histologic Changes Associated With Neoadjuvant Chemotherapy Are Predictive of Nodal Metastases in Patients With High-Risk Prostate Cancer
- (2010) Catherine O’Brien et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Brca2 and Trp53 Deficiency Cooperate in the Progression of Mouse Prostate Tumourigenesis
- (2010) Jeffrey C. Francis et al. PLoS Genetics
- Morphologic Characterization of Preoperatively Treated Prostate Cancer: Toward a Post-Therapy Histologic Classification
- (2009) Eleni Efstathiou et al. EUROPEAN UROLOGY
- High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancer
- (2009) Adrian S. Ishkanian et al. PROSTATE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started